Cost of surgical treatment for breast cancer

Update Date: Source: Network

summary

Recently, my aunt's breast swelling and pain, he thought it was some inflammation and didn't care about it, until one day when she couldn't stand the pain and went to the hospital for examination, the doctor told her it was breast cancer. And the discovery time is relatively early, so the hope of cure is relatively large, but the cost is much. Now let me tell you about the cost of breast cancer surgery.

Cost of surgical treatment for breast cancer

The first factor affecting the price: the cost of chemotherapy varies greatly according to different drugs and schemes. If it is CEF scheme, it is about 2500-3000 yuan / course of treatment, and adjuvant drugs are not included. If it is TAC and et scheme, it is about 5000 yuan / course of treatment for domestic ones, and 8000-10000 yuan / course of treatment for imported ones. If the original CMF scheme is used, each course of treatment costs only a few hundred yuan.

The second factor affecting the price: adjuvant drugs are not the same in every hospital. Doctors in cancer hospitals like to use some immunomodulators and nutrition drugs. The curative effect has not been significantly improved, but the cost is high. Different patients receive chemotherapy, the drugs are different, so it is difficult to make clear about the cost.

Three factors affecting the price: for early, middle and late breast cancer patients, the specific implementation of radiotherapy program is different, there are more detailed programs for specific conditions. Moreover, there are three-dimensional conformal radiotherapy, body gamma knife, intensity-modulated radiotherapy and many other ways of radiotherapy. The equipment used is different, and the cost is also different.

matters needing attention

During chemotherapy, patients should adjust their immune function, repair their damaged cells, effectively alleviate the side effects of chemotherapy, stimulate the formation of leukocytes, and have a better prognosis.